These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8946272

  • 1. The effects of dexfenfluramine on weight loss and cardiovascular risk factors in female patients with upper and lower body obesity.
    Ditschuneit HH, Flechtner-Mors M, Adler G.
    J Cardiovasc Risk; 1996 Aug; 3(4):397-403. PubMed ID: 8946272
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
    O'Connor HT, Richman RM, Steinbeck KS, Caterson ID.
    Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
    [Abstract] [Full Text] [Related]

  • 4. Dexfenfluramine as an adjunct to a reduced-fat, ad libitum diet: effects on body composition, nutrient intake and cardiovascular risk factors.
    Swinburn BA, Carmichael HE, Wilson MR.
    Int J Obes Relat Metab Disord; 1996 Nov; 20(11):1033-40. PubMed ID: 8923161
    [Abstract] [Full Text] [Related]

  • 5. Dexfenfluramine reduces cardiovascular risk factors.
    Bremer JM, Scott RS, Lintott CJ.
    Int J Obes Relat Metab Disord; 1994 Apr; 18(4):199-205. PubMed ID: 8044193
    [Abstract] [Full Text] [Related]

  • 6. Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.
    Davis R, Faulds D.
    Drugs; 1996 Nov; 52(5):696-724. PubMed ID: 9118819
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Pharmacological therapy of obesity].
    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of dexfenfluramine on body weight, blood pressure, insulin resistance and serum cholesterol in obese individuals.
    Holdaway IM, Wallace E, Westbrooke L, Gamble G.
    Int J Obes Relat Metab Disord; 1995 Oct; 19(10):749-51. PubMed ID: 8589769
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of fenfluramine and dexfenfluramine in the treatment of obesity: a meta-analysis.
    Carvajal A, García del Pozo J, Martín de Diego I, Rueda de Castro AM, Velasco A.
    Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):285-90. PubMed ID: 11031729
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour.
    Mathus-Vliegen EM, van de Voorde K, Kok AM, Res AM.
    J Intern Med; 1992 Aug; 232(2):119-27. PubMed ID: 1506807
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks.
    Drent ML, Zelissen PM, Koppeschaar HP, Nieuwenhuyzen Kruseman AC, Lutterman JA, van der Veen EA.
    Int J Obes Relat Metab Disord; 1995 May; 19(5):299-304. PubMed ID: 7647820
    [Abstract] [Full Text] [Related]

  • 19. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group.
    Weissman NJ, Tighe JF, Gottdiener JS, Gwynne JT.
    N Engl J Med; 1998 Sep 10; 339(11):725-32. PubMed ID: 9731088
    [Abstract] [Full Text] [Related]

  • 20. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
    Pontiroli AE, Pacchioni M, Piatti PM, Cassisa C, Camisasca R, Pozza G.
    J Clin Endocrinol Metab; 1996 Oct 10; 81(10):3727-32. PubMed ID: 8855830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.